Salvador Aznar Benitah receives the “Premio Fundación Carmen y Severo Ochoa 2019” Blog Post

Salvador Aznar Benitah, ICREA at the Institute for Research in Biomedicine (IRB Barcelona) in the Barcelona Science Park, as received the “Premio Carmen y Severo Ochoa de Investigación en Biología Molecular” in acknowledgement of his work on adult stem cells and the relation of these with circadian rhythms and metastasis, and also in recognition of his recent entrepreneurial activity as co-founder of Ona Therapeutics.

 

IBEC presents its capabilities in 3D bioprinting at the 4th edition of INDUSTRY Blog Post

The Institute for Bioengineering of Catalonia (IBEC), based in the Barcelona Science Park, participated in the fourth edition of INDUSTRY From Needs to Solutions, which took place from 29th to 31st October at Fira Barcelona´s Gran Via venue. The event brought together more than 150 companies in its exhibition area and 150 speakers within the framework of Barcelona Industry Week, that brought together seven major events related to digital transformation at Fira Barcelona. IoT Solutions World Congress, Blockchain Solutions World and AI & Cognitive Systems Forum were other events that added to this great summit where the achievements and innovations of disruptive technologies in the field of health became evident.

 

Scientists build machine learning-based algorithm to predict which cancer patients benefit from immunotherapy Blog Post

Scientists at the Institute for Research in Biomedicine (IRB Barcelona) in the Barcelona Science Park, in collaboration with the Centre for Genomic Regulation (CRG) and Radboud University, have built a tool that detects genetic mutations that trigger the immune system, helping identify which cancer patients are more likely to benefit from immunotherapy. The algorithm also reveals which people living with hereditary diseases may benefit from drugs that already exist. The new technology’s potential is described today in Nature Genetics.

 

Rob Surgical, a spin-off from IBEC and UPC, closes a €5 million investment round Blog Post

Rob Surgical, a spin-off created by the Institute for Bioengineering of Catalonia (IBEC), based in the PCB, and the Polytechnic University of Catalonia (UPC) in 2012, has closed a €5 million investment round with the Dutch holding Scranton Enterprises to fund the final phase of the new Bitrack System –an alternative to the current laparoscopy surgical robot Da Vinci– and launch the product onto the market.

 

Researchers from IBEC and IRB Barcelona awarded by “la Caixa” for their pioneering research projects Blog Post

On 16 September, ”la Caixa” Banking Foundation presented the 79 grants for national and international research and innovation projects of excellence. Among the beneficiaries of funding from ”la Caixa” are researchers Eduard Batlle, Raúl Méndez, Meritxell Teixidó and Enrique Marcos, from the Institute for Research in Biomedicine (IRB Barcelona), and José Antonio del Río, Pau Gorostiza and Samuel Sánchez, from the Institute for Bioengineering of Catalonia (IBEC).

 

A research team develops a mini-factory of human cardiac tissue Blog Post

Researchers from the Institute for Bioengineering of Catalonia (IBEC) at the Barcelona Science Park, in collaboration with scientists from the Centre of Regenerative Medicine in Barcelona (CMR[B]), the University of Barcelona (UB), the Polytechnic University of Catalonia (UPC) and the CIBER-BBN have developed a system which is capable of producing tissues in a laboratory that simulate the behaviour of the human heart. The new platform, named CardioSlice, could be used to pre-evaluate the toxicity of drugs in the heart without using animal models. The results of this innovation work have announced in an article recently published in the journal Stem Cell Reports.

 

CataloniaBioHT participates in the Annual Advisory Committee of the Catalonia’s Cluster Programme Blog Post

Last Thursday, the president of CataloniaBio & HealthTech (CataloniaBioHT), Jaume Amat, participated in the Annual Advisory Committee of the Catalonia’s Cluster Programme, promoted by ACCIÓ, alongside the other presidents of the 30 accredited clusters. The association, founded in 2017 as a result of the merger of CataloniaBio and HeathTech Cluster and headquartered in the Barcelona Science Park, has over 160 companies and agents in the field of biomedicine and health.